Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations.

Levis MJ, Perl AE, Altman JK, Gocke CD, Bahceci E, Hill J, Liu C, Xie Z, Carson AR, McClain V, Stenzel TT, Miller JE.

Blood Adv. 2018 Apr 24;2(8):825-831. doi: 10.1182/bloodadvances.2018015925.

2.

Next-generation POC urine pregnancy analyzers.

Stenzel TT, de Callier R.

MLO Med Lab Obs. 2014 Jul;46(7):42. No abstract available.

PMID:
25158404
3.

An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for southern blot analysis.

Chen L, Hadd A, Sah S, Filipovic-Sadic S, Krosting J, Sekinger E, Pan R, Hagerman PJ, Stenzel TT, Tassone F, Latham GJ.

J Mol Diagn. 2010 Sep;12(5):589-600. doi: 10.2353/jmoldx.2010.090227. Epub 2010 Jul 8.

4.

A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome.

Filipovic-Sadic S, Sah S, Chen L, Krosting J, Sekinger E, Zhang W, Hagerman PJ, Stenzel TT, Hadd AG, Latham GJ, Tassone F.

Clin Chem. 2010 Mar;56(3):399-408. doi: 10.1373/clinchem.2009.136101. Epub 2010 Jan 7.

5.

Morphologic examination of sequential bone marrow biopsies after nonmyeloablative stem cell transplantation complements molecular studies of donor engraftment.

Lagoo AS, Gong JZ, Stenzel TT, Goodman BK, Buckley PJ, Chao NJ, Gasparetto C, Long GD, Rizzieri DA.

Arch Pathol Lab Med. 2006 Oct;130(10):1479-88.

PMID:
17090189
6.

Evaluation of expression based markers for the detection of breast cancer cells.

Brown NM, Stenzel TT, Friedman PN, Henslee J, Huper G, Marks JR.

Breast Cancer Res Treat. 2006 May;97(1):41-7. Epub 2005 Dec 1.

PMID:
16319979
7.

Characterization of publicly available lymphoblastoid cell lines for disease-associated mutations in 11 genes.

Bernacki SH, Beck JC, Muralidharan K, Schaefer FV, Shrimpton AE, Richie KL, Levin BC, Pont-Kingdon G, Stenzel TT.

Clin Chem. 2005 Nov;51(11):2156-9. No abstract available.

8.

Genetically characterized positive control cell lines derived from residual clinical blood samples.

Bernacki SH, Beck JC, Stankovic AK, Williams LO, Amos J, Snow-Bailey K, Farkas DH, Friez MJ, Hantash FM, Matteson KJ, Monaghan KG, Muralidharan K, Pratt VM, Prior TW, Richie KL, Levin BC, Rohlfs EM, Schaefer FV, Shrimpton AE, Spector EB, Stolle CA, Strom CM, Thibodeau SN, Cole EC, Goodman BK, Stenzel TT.

Clin Chem. 2005 Nov;51(11):2013-24. Epub 2005 Sep 15.

9.

Primary intraocular T-cell-rich large B-cell lymphoma.

Cummings TJ, Stenzel TT, Klintworth G, Jaffe GJ.

Arch Pathol Lab Med. 2005 Aug;129(8):1050-3.

PMID:
16048400
10.

The value of fluorescence in situ hybridization and polymerase chain reaction in the diagnosis of B-cell non-Hodgkin lymphoma by fine-needle aspiration.

Safley AM, Buckley PJ, Creager AJ, Dash RC, Dodd LG, Goodman BK, Jones CK, Lagoo AS, Stenzel TT, Wang W, Xie B, Gong JZ.

Arch Pathol Lab Med. 2004 Dec;128(12):1395-403.

PMID:
15578884
11.

Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation.

Snyder MJ, Stenzel TT, Buckley PJ, Lagoo AS, Rizzieri DA, Gasparetto C, Vredenburgh JJ, Chao NJ, Gong JZ.

Am J Surg Pathol. 2004 Jun;28(6):794-800.

PMID:
15166672
12.
13.

Multicenter characterization and validation of the intron-8 poly(T) tract (IVS8-T) status in 25 Coriell cell repository cystic fibrosis reference cell lines for cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation assays.

Sebastian S, Spitzer SG, Grosso LE, Amos J, Schaefer FV, Lyon E, Wolff DJ, Hajianpour A, Taylor AK, Millson A, Stenzel TT.

Clin Chem. 2004 Jan;50(1):251-4. No abstract available.

14.

Phase II trial of gefitinib in recurrent glioblastoma.

Rich JN, Reardon DA, Peery T, Dowell JM, Quinn JA, Penne KL, Wikstrand CJ, Van Duyn LB, Dancey JE, McLendon RE, Kao JC, Stenzel TT, Ahmed Rasheed BK, Tourt-Uhlig SE, Herndon JE 2nd, Vredenburgh JJ, Sampson JH, Friedman AH, Bigner DD, Friedman HS.

J Clin Oncol. 2004 Jan 1;22(1):133-42. Epub 2003 Nov 24.

PMID:
14638850
15.

Bioelectronic sensor technology for detection of cystic fibrosis and hereditary hemochromatosis mutations.

Bernacki SH, Farkas DH, Shi W, Chan V, Liu Y, Beck JC, Bailey KS, Pratt VM, Monaghan KG, Matteson KJ, Schaefer FV, Friez M, Shrimpton AE, Stenzel TT.

Arch Pathol Lab Med. 2003 Dec;127(12):1565-72.

PMID:
14632577
16.

Estimated analytic validity of HFE C282Y mutation testing in population screening: the potential value of confirmatory testing.

Palomaki GE, Haddow JE, Bradley LA, Richards CS, Stenzel TT, Grody WW.

Genet Med. 2003 Nov-Dec;5(6):440-3.

PMID:
14614395
17.

Establishment of stably EBV-transformed cell lines from residual clinical blood samples for use in performance evaluation and quality assurance in molecular genetic testing.

Bernacki SH, Stankovic AK, Williams LO, Beck JC, Herndon JE, Snow-Bailey K, Prior TW, Matteson KJ, Wasserman LM, Cole EC, Stenzel TT.

J Mol Diagn. 2003 Nov;5(4):227-30.

18.

Cytogenetic and molecular analysis of an unusual case of acute promyelocytic leukemia with a t(15;17;17)(q22;q23;q21).

Tirado CA, Golembiewski-Ruiz V, Horvatinovich J, Moore JO, Buckley PJ, Stenzel TT, Goodman BK.

Cancer Genet Cytogenet. 2003 Aug;145(1):31-7.

PMID:
12885460
19.

Burkitt lymphoma arising in organ transplant recipients: a clinicopathologic study of five cases.

Gong JZ, Stenzel TT, Bennett ER, Lagoo AS, Dunphy CH, Moore JO, Rizzieri DA, Tepperberg JH, Papenhausen P, Buckley PJ.

Am J Surg Pathol. 2003 Jun;27(6):818-27.

PMID:
12766587
20.

Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplants.

Morse MA, Rizzieri D, Stenzel TT, Hobeika AC, Vredenburgh JJ, Chao NJ, Clay TM, Mosca PJ, Lyerly HK.

J Hematother Stem Cell Res. 2002 Aug;11(4):659-68.

PMID:
12201954
22.

Molecular markers of prognosis in astrocytic tumors.

Rasheed A, Herndon JE, Stenzel TT, Raetz JG, Kendelhardt J, Friedman HS, Friedman AH, Bigner DD, Bigner SH, McLendon RE.

Cancer. 2002 May 15;94(10):2688-97.

23.

Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen.

Rizzieri DA, Long GD, Vredenburgh JJ, Gasparetto C, Morris A, Stenzel TT, Davis P, Chao NJ.

Blood. 2001 Dec 1;98(12):3486-8.

PMID:
11719394
24.

Fluorescent, multiplexed, automated, primer-extension assay for 3120+1G-->A and I148T mutations in cystic fibrosis.

Brown NM, Bernacki S, Pratt VM, Stenzel TT.

Clin Chem. 2001 Nov;47(11):2053-5. No abstract available.

25.

Quality control in molecular genetic testing.

Dequeker E, Ramsden S, Grody WW, Stenzel TT, Barton DE.

Nat Rev Genet. 2001 Sep;2(9):717-23. doi: 10.1038/35088588. Review.

PMID:
11533720
26.

The pathology of liver-localized post-transplant lymphoproliferative disease: a report of three cases and a review of the literature.

Nuckols JD, Baron PW, Stenzel TT, Olatidoye BA, Tuttle-Newhall JE, Clavien PA, Howell DN.

Am J Surg Pathol. 2000 May;24(5):733-41. Review.

PMID:
10800993
27.

Evaluation of an automated technique for assessment of marrow engraftment after allogeneic bone marrow transplantation using a commercially available kit.

Nuckols JD, Rasheed BK, McGlennen RC, Bigner SH, Stenzel TT.

Am J Clin Pathol. 2000 Jan;113(1):135-40.

PMID:
10631867
28.

Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.

Noll WW, Belloni DR, Stenzel TT, Grody WW.

Nat Genet. 1999 Nov;23(3):271-2. No abstract available.

PMID:
10610176
29.

Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results

Noll WW, Belloni DR, Stenzel TT, Grody WW.

Nat Genet. 1999 Nov;23(3):271-2. No abstract available.

PMID:
10545943
30.

Translocation (15;17)(q22;q21) as a secondary chromosomal abnormality in a case of acute monoblastic leukemia with tetrasomy 8.

Zhang XX, Robinson LJ, Stenzel TT, Qumsiyeh MB.

Cancer Genet Cytogenet. 1999 Aug;113(1):9-13.

PMID:
10459339
31.

Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.

Bigner SH, Matthews MR, Rasheed BK, Wiltshire RN, Friedman HS, Friedman AH, Stenzel TT, Dawes DM, McLendon RE, Bigner DD.

Am J Pathol. 1999 Aug;155(2):375-86.

32.

Multiple myeloma-associated amyloidosis and giant cell arteritis.

Estrada A, Stenzel TT, Burchette JL, Allen NB.

Arthritis Rheum. 1998 Jul;41(7):1312-7.

PMID:
9663490
33.

Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles.

Gallione CJ, Klaus DJ, Yeh EY, Stenzel TT, Xue Y, Anthony KB, McAllister KA, Baldwin MA, Berg JN, Lux A, Smith JD, Vary CP, Craigen WJ, Westermann CJ, Warner ML, Miller YE, Jackson CE, Guttmacher AE, Marchuk DA.

Hum Mutat. 1998;11(4):286-94.

PMID:
9554745
34.

PTEN gene mutations are seen in high-grade but not in low-grade gliomas.

Rasheed BK, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD, Bigner SH.

Cancer Res. 1997 Oct 1;57(19):4187-90.

35.

The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2.

Berg JN, Gallione CJ, Stenzel TT, Johnson DW, Allen WP, Schwartz CE, Jackson CE, Porteous ME, Marchuk DA.

Am J Hum Genet. 1997 Jul;61(1):60-7.

36.

Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia.

Washington K, Stenzel TT, Buckley RH, Gottfried MR.

Am J Surg Pathol. 1996 Oct;20(10):1240-52.

PMID:
8827031
37.

Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2.

Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, Stenzel TT, Speer M, Pericak-Vance MA, Diamond A, Guttmacher AE, Jackson CE, Attisano L, Kucherlapati R, Porteous ME, Marchuk DA.

Nat Genet. 1996 Jun;13(2):189-95.

PMID:
8640225
38.

Replication of plasmid R6K origin gamma in vitro. Dependence on dual initiator proteins and inhibition by transcription.

MacAllister TW, Kelley WL, Miron A, Stenzel TT, Bastia D.

J Biol Chem. 1991 Aug 25;266(24):16056-62.

39.

Cooperativity at a distance promoted by the combined action of two replication initiator proteins and a DNA bending protein at the replication origin of pSC101.

Stenzel TT, MacAllister T, Bastia D.

Genes Dev. 1991 Aug;5(8):1453-63. Erratum in: Genes Dev 1991 Dec;5(12A):2362.

40.
41.

NMR studies of combined lanthanide shift and relaxation agents for differential characterization of 23Na in a two-compartment model system.

Brown MA, Stenzel TT, Ribeiro AA, Drayer BP, Spicer LD.

Magn Reson Med. 1986 Apr;3(2):289-95.

PMID:
2423838

Supplemental Content

Loading ...
Support Center